Use of drug reduces likelihood of progression to multiple sclerosis
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon ...
Apr 19, 2012
0
0